Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis - Université Paris-Est-Créteil-Val-de-Marne Accéder directement au contenu
Article Dans Une Revue Targeted Oncology Année : 2022

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis

Résumé

Background Information on the epidemiology of uncommon EGFR mutations including exon 20 insertions amongst nonsmall-cell lung cancer (NSCLC) is lacking. Objective The objective of this pragmatic literature review (PLR) and meta-analysis was to generate robust prevalence and incidence estimates based on ranges of exon 20 insertion mutations reported in the literature. Materials and methods Searches of MEDLINE, Embase, congresses and reference lists for articles published from 2013 in key European countries of interest

Domaines

Cancer
Fichier principal
Vignette du fichier
11523_2022_Article_868.pdf (2.08 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-04141993 , version 1 (26-06-2023)

Identifiants

Citer

Suzy van Sanden, Molly Murton, Anna Bobrowska, Nora Rahhali, Jan Sermon, et al.. Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis. Targeted Oncology, 2022, 17 (2), pp.153 - 166. ⟨10.1007/s11523-022-00868-z⟩. ⟨hal-04141993⟩

Collections

IMRB UPEC
3 Consultations
16 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More